Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.50 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.50 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | PDE5A | O76074 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9857635 | 1.00 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1SOAT2SOAT1TNNC1 | |
| SCHEMBL6046925 | 0.89 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1SOAT2SOAT1TNNC1 | |
| SCHEMBL10482163 | 0.83 | CYSLTR2 (0.48) | CYSLTR2CYSLTR1SOAT2SOAT1TNNC1 | |
| SCHEMBL10482169 | 0.83 | CYSLTR2 (0.48) | CYSLTR2CYSLTR1SOAT2SOAT1TNNC1 | |
| SCHEMBL10617350 | 0.83 | CYSLTR2 (0.48) | CYSLTR2CYSLTR1SOAT2SOAT1TNNC1 | |
| SCHEMBL10383342 | 0.83 | CYSLTR2 (0.48) | CYSLTR2CYSLTR1SOAT2SOAT1TNNC1 | |
| SCHEMBL489152 | 0.83 | CYSLTR2 (0.47) | CYSLTR2CYSLTR1SOAT2SOAT1TNNC1 | |
| SCHEMBL1277029 | 0.83 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1SOAT2SOAT1EPHX2 | |
| SCHEMBL1001648 | 0.83 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1SOAT2SOAT1EPHX2 | |
| SCHEMBL9857570 | 0.83 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1SOAT2SOAT1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0301401-B1 | LEUKOTRIENE ANTAGONISTS, PROCESS FOR THEIR PREPARATION, THEIR USE IN THE TREATMENT OF ILLNESSES | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-11-27 | — | — | EP | disclosed |
| US-4851440-A | ASTHMA | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | disclosed |
| EP-0301401-A2 | Leukotriene antagonists, process for their preparation, their use in the treatment of illnesses | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-02-01 | — | — | EP | disclosed |